Loading…
Based on limited metadata, Bioptimal International, a medical device company, received an FDA Warning Letter on April 3, 2024. While the specific violations cannot be determined due to unavailable subject line and letter details, the warning indicates regulatory concerns with one or more of the company's device products. Without access to the full letter text or issuing office designation, the precise nature of the compliance issues and their regulatory scope cannot be specified from this metadata alone.